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Introduction: It is not well understood whether the process of autophagy is accelerated or blocked in sepsis, and
whether it is beneficial or harmful to the immune defense mechanism over a time course during sepsis. Our aim
was to determine both the kinetics and the role of autophagy in sepsis.
Methods: We examined autophagosome and autolysosome formation in a cecal ligation and puncture (CLP)
mouse model of sepsis (in C57BL/6N mice and GFP-LC3 transgenic mice), using western blotting,
immunofluorescence, and electron microscopy. We also investigated the effect of chloroquine inhibition of
autophagy on these processes.
Results: Autophagy, as demonstrated by increased LC3-II/LC3-I ratios, is induced in the liver, heart, and spleen over
24 h after CLP. In the liver, autophagosome formation peaks at 6 h and declines by 24 h. Immunofluorescent
localization of GFP-LC3 dots (alone and with lysosome-associated membrane protein type 1 (LAMP1)), as well as
electron microscopic examination, demonstrate that both autophagosomes and autolysosomes are increased after
CLP, suggesting that intact autophagy mechanisms operate in the liver in this model. Furthermore, inhibition of
autophagy process by chloroquine administration immediately after CLP resulted in elevated serum transaminase
levels and a significant increase in mortality.
Conclusions: All autophagy-related processes are properly activated in the liver in a mouse model of sepsis;
autophagy appears to play a protective role in septic animals.Introduction
Sepsis is a life-threatening condition that causes multiple
organ failure and shock. It initiates host immune, in-
flammatory, and coagulation responses that cause tissue
injury, hypoxia and organ dysfunction and predispose
patients to refractory infection [1]. Despite advances in
critical care treatment and increased understanding of
the pathophysiology of sepsis, the mortality rate of affec-
ted patients remains high (40 to 60%) even in developed
countries [2]. This is particularly important as the inci-
dence of sepsis increases in an expanding aged popula-
tion with treatment-resistant infections and compromised
immune function. Excessive levels of pro-inflammatory* Correspondence: hatanom@faculty.chiba-u.jp
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reproduction in any medium, provided the orcytokines and chemokines cause subsequent accumulation
of neutrophils and immune cells, which release reactive
oxygen species and proteases. These mediators and dy-
soxia induce cell death and subsequent organ dys-
function [3].
Autophagy is a bulk intracellular degradation system
responsible for disposal of damaged and senescent orga-
nelles and denatured proteins using lysosomal processes
[4-6]. Autophagy involves the formation of specialized
double-membrane vesicles - autophagosomes - which
envelop target cytosolic materials and then secondarily
fuse with lysosomes, followed by enzymatic degradation
of both the inner membrane of the autophagosome
and its contents. The resultant structure is a single-
membrane organelle, the autolysosome. The electron mi-
croscopic appearance of autolysosomes as contents fur-
ther degrade over time forms the morphologic spectrum
of heterolysosomes. Macromolecules resulting from thisral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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anabolic pathways and energy production [7,8].
Under physiological conditions, autophagy plays impor-
tant roles in pre-implantation embryonic development,
survival during neonatal starvation, and cell differentiation
of lymphocytes, erythrocytes, and adipocytes [9-13]. Au-
tophagy is also crucial to the maintenance of terminally
differentiated cells, such as neurons [14-16]. Autophagy is
induced beyond basal levels in response to environmental
signals (such as fasting), hormones (such as glucagon),
and microbial pathogens [17-19] and aids cell survival by
producing energy during starvation, and eliminating path-
ogens from infected cells [6,8,19].
Recent studies have demonstrated that autophagy is
also induced in patients with sepsis and in the clinically
relevant cecal ligation and puncture (CLP) animal model
of sepsis [20-27]. Autophagic structures can be identified
by electron microscopy in livers of patients who died of
sepsis, and the number of these structures is significantly
greater than that seen in non-septic control patients
[28]. Autophagy is also induced in the heart and lungs in
the CLP model [20,24]. However, it is not yet well-
defined as to what extent the process of autophagy is
completed, whether it is accelerated, or indeed, whether
it is at times partially or completely blocked prior to fu-
sion of autophagosomes with lysosomes. It is also not
known with clarity whether autophagy is generally bene-
ficial or harmful to the immune defense mechanism or
other cell functions in sepsis.
In this study, we investigated both the kinetics of au-
tophagy and importance of this process to survival in
sepsis using a mouse CLP model. We found that the en-
tire autophagy system (from autophagosome formation
to degradation of lysosomal contents) functions in the
CLP mouse liver over a 24-h post-CLP observation
period, and demonstrated that inhibition of autophagy
results in hepatocyte damage and decreased survival
compared to sham-treated control animals. We use
these observations to discuss the role of autophagy in
sepsis.Materials and methods
Animals
Male C57BL/6N (6- to 8-week-old) mice and green
fluorescent protein (GFP)- microtubule-associated pro-
tein light chain 3 (LC3) transgenic mice (C57BL/6 back-
ground; 6- to 8-week-old) were acclimated to a 12-h
day/night cycle under specific pathogen-free conditions
with food at least 1 week before experiments. All experi-
mental procedures were approved by the Institutional
Animal Care and Use Committees of Chiba University
and were in compliance with the National Institute of
Health guidelines.Cecal Ligation and Puncture (CLP) model
Sepsis was induced by CLP as described previously
[29,30]. Briefly, mice were anesthetized with isoflurane
and after laparotomy, the cecum was ligated with a 3-0
silk tie and punctured with a 25-gauge needle at two
sites, followed by expression of a small amount of fecal
material into the peritoneal cavity. After surgery, 2 ml of
0.9% saline was injected subcutaneously. Sham-operated
mice were treated with the same procedure, but without
cecum ligation and puncture. No antibiotics or analge-
sics were used, and mice were food-deprived but had
free access to water postoperatively. In selected animals,
chloroquine (60 mg/kg) was injected intra-peritoneally 1
h after the operation [31]. Mice were sacrificed at indi-
cated time points after treatment and tissue samples
were taken for analysis. Survival was examined after chlo-
roquine administration (n = 18). Mice were observed
every day by animal caretakers who were blinded to the
treatment arms, and the mice were sacrificed when they
were moribund.
Western blot analysis
Total proteins were prepared from mouse organs. Each
tissue was lysed in 2 × SDS sampling buffer (1.245 M
Tris-HCl at pH 6.8 containing 10% glycerol, 4.6% so-
dium dodecyl sulfate, 10% 2-mercaptoethanol, and
0.04% bromophenol blue). Extracts were homogenized
on ice and boiled for 5 minutes; these were then cen-
trifuged at 10,000 × g for 10 minutes at room tem-
perature, and the supernatants were obtained as total
protein.
Equal amounts of protein were separated by SDS-
polyacrylamide gel electrophoresis and transferred to
polyvinylidene difluoride membrane. The membranes were
subsequently incubated with 5% nonfat dry milk in Tris-
buffered saline (TBS) containing 0.1% Tween-20 (TBS-T)
for 1 h at room temperature. Antibodies were added and
incubated overnight at 4°C in TBS-T. The following pri-
mary antibodies were used: rabbit polyclonal anti-LC3B
(Sigma-Aldrich, St. Louis, MO; 1:1000), mouse monoclonal
anti-β tubulin (clone E7; Developmental Studies Hybridoma
Bank, Iowa city, IA, 1:1000), rabbit polyclonal anti-p62
(DakoCytomation, Glostrup, Denmark, 1:500). Membranes
were washed 3 times in TBS-T and subsequently incubated
with peroxidase conjugated secondary antibodies (goat
anti-rabbit IgG: Jackson Immuno Research, West Grove,
PA, 1:2000; goat anti-mouse IgG: Jackson Immuno Re-
search, 1:2000). Blots were washed three times with TBS-T
and once with TBS, and the signal was then detected using
enhanced chemiluminescence (ECL-Plus) reagent (GE
Healthcare, Piscataway, NJ, USA). Band images were
scanned and densitometric analysis was performed using
NIH Image software (Bethesda, MD, USA). Quantification
data, evaluated by band-intensity of LC3-I and -II, were
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of seven independent experiments.Real-time quantitative reverse transcription Polymerase
Chain Reaction (PCR)
Total RNA was extracted from the liver tissue using
RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA), and
single-stranded cDNA was synthesized with SuperScript
VILO cDNA Synthesis Kit (Life Technologies, Grand
Island, NY). The expression of LC3 mRNA was deter-
mined by quantitative real-time PCR with the cDNA, using
a SYBR Green PCR Master Mix (Life Technologies) and
run on the StepOne Real-Time PCR System (Life Tech-
nologies). The mRNA levels were measured as the relative
ratio to the β-actin mRNA levels. The quantification data
were analyzed with the LightCycler analysis software as de-





Mice were transcardially perfused with 4% paraformalde-
hyde (PFA) in phosphate buffer. Tissues of interest were
removed and were further fixed with 4% PFA at 4°C
overnight. Samples were then placed in 15% sucrose in
PBS at 4°C for 4 h; this was then exchanged for 30% su-
crose in PBS, and incubation continued at 4°C overnight.
The tissues were frozen in optimum cutting temperature
(OCT) compound and sectioned serially into 4-μm-thick
sections using a cryostat [33]. Samples were kept frozen
at -80°C until used.
For immunofluorescence, sections were stained using
rabbit polyclonal anti-lysosome-associated membrane
protein type 1 (LAMP1) (Abcam, Cambridge, UK;
1:1000). Cy3-conjugated goat anti-rabbit immuno-
globulin G (IgG) (H+L) was used as a secondary anti-
body (Jackson Immuno Research; 1:1000 dilution). All
fluorescence images were digitally acquired with an Olym-
pus Fluoview 1000 confocal microscope (Olympus Amer-
ica, Inc., Center Valley, PA, USA).Electron microscopic analysis
Samples were fixed with 2% PFA, and 2% glutaraldehyde
in 0.1 M phosphate buffer, pH 7.4, at 4°C overnight.
After fixation and dehydration, 70-nm sections were pre-
pared with a diamond blade, using an ultramicrotome
(ULTRACUT UCT; Leica) and mounted on metal grids.
These were stained with 2% uranyl acetate and secon-
darily stained with lead solution and examined with a
transmission electron microscope (JEM-1200EX; JEOLLtd., Tokyo, Japan). Specimens were examined as previ-
ously described [28]. Briefly, a minimum of 8 to 10 random
fields (to minimize unintended sampling bias) were exami-
ned at 2,500× magnification for evidence of autophagy or
cell injury/death, and the number of autophagosomes and
autolysosomes in each 2,500× image was counted. The
mean ± SD per 50 images from each mouse was calculated
and the data from different groups were compaired
(CLP (n = 3) versus sham (n = 3)).
In the present study, autophagosomes were defined as
double-membrane structures that enclosed cytoplasm
with damaged organelles in various stages of degrad-
ation; double membrane structures enclosing only mate-
rials that resembled background cytoplasm were not
counted. Autolysosomes were defined as single mem-
brane vesicles with cytoplasmic or organellar debris in
various stages of degradation (usually less obviously the
remains of specific organelles compared with autophago-
someal contents). Lysosomes with amorphous electron-
dense material (heterolysosomes) were not counted. Be-
cause initial counting of images was performed by the
same investigator who created the images (EW), the pos-
sibility of unintended bias was mitigated by providing
the same set of images in a blinded fashion to a second
investigator (PES). When results of initial counting
differed markedly between observers, relevant images
were re-evaluated and discrepancies were resolved. The
2,500× survey images used in this analysis represent
approximately 3,000 square microns of tissue, each
containing 5 to 8 hepatocytes and a variable comple-
ment of Kupffer cells, stellate cells, sinusoidal endothe-
lial cells and inflammatory cells. Only the hepatocytes
were counted.
Histological analysis
Liver tissue specimens were obtained and sections of
formalin-fixed paraffin-embedded liver samples were
stained with hematoxylin-eosin to assess the degree of
liver injury.
Analysis of transaminase to assess liver injury
Blood samples were obtained from the tail arteries of
mice (n = 7). Serum aspartate aminotransferase (AST)
and alanine aminotransferase (ALT) activity was quanti-
fied using the transaminase C-ll test (Wako Chemical,
Tokyo, Japan).
Statistical analysis
All data were analyzed for statistical significance using
the Mann-Whitney test or one-way analysis of variance,
and individual group means were then compared with a
Student-Newman-Keuls test. All data were expressed as
the mean ± SD using the statistical software program
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Overall survival was calculated using the Kaplan-Meier
method, and comparisons were evaluated using the
log-rank test. Data were analyzed using SPSS 21.0 soft-
ware. P-values <0.05 were considered to be statistically
significant.
Results
Autophagosome formation in various organs after cecal
ligation and puncture in mice
Autophagy is induced under various types of stress.
Autophagosome formation, the initial step of autophagy,
can be assessed by following the conversion of cytosolic
LC3-I protein (17 kDa) to autophagosomal membrane-
bound LC3-II (15 kDa) by SDS-PAGE. We examined in-
duction of autophagy after CLP in various organs. Liver,
spleen, heart, mesenteric lymph nodes, and kidney were
isolated at 1, 3, 6, 12, or 24 h after CLP and auto-
phagosome formation in these organs evaluated by west-
ern blotting. In the sham-operated mice, the LC3-II/
LC3-I ratio slightly increased over the time course
following surgery and declined by 24 h after surgery
(Figure 1A). In the liver, a significant increase in LC3-II/
LC3-I ratio was observed at 6 h after CLP, and the ratio
returned to basal levels by 24 h (Figure 1A,B). The same
tendency was observed in the heart and spleen (Figure 1C).
In contrast, minimal or no change was seen in the ratio in
the mesenteric lymph node and kidney over the time
course following CLP (Figure 1C).
Since the liver is one of the critical organs in sepsis
and induction of autophagy was greatest in the liver in
this study, based on LC3-II/LC3-I ratios, we focused on
the liver in subsequent analyses. To further investigate
LC3 induction, we examined LC3 mRNA expression in
the liver. The expression significantly increased 1 and 3
h after CLP compared to the sham group (Figure 1D),
indicating that the total amount of LC3 protein in the
liver increased at a transcriptional level and was then
converted to LC3-II post-transcriptionally. Autophago-
some formation was also examined using GFP-LC3
transgenic mice. In these mice, autophagosomes are vi-
sualized as cytoplasmic GFP-LC3 dots by confocal mi-
croscopy. In agreement with the western blotting data,
CLP induced an increase in GFP-LC3 dots; the number
peaked at 6 h (27.6 ± 9.1/cell) and then decreased by
24 h (18.3 ± 5.8/cell) in the liver (Figure 1E,F). No sig-
nificant increase in GFP-LC3 dots was observed in the
sham-operated group.
Completion of autophagy induction in the liver after CLP
An increase in autophagosome numbers does not ne-
cessarily infer completion of the autophagy process.
The autophagosome fuses with a lysosome to form an
autolysosome. Blockade of autophagy at this step wouldalso result in an increased number of autophagosomes. In
order to distinguish these possibilities, fusion of autopha-
gosomes with lysosomes was examined by immunofluo-
rescence. Co-localization of GFP-LC3 dots and signals for
LAMP1, a lysosomal marker, was evaluated in the liver
after CLP. As shown in Figure 2A, increased co-loca-
lization of LAMP1 and GFP-LC3 was observed in the
CLP group compared with the sham-operated group at
both 6 h (7.0 ± 3.1 in CLP versus 0.5 ± 0.7 in sham) and
24 h (10.7 ± 4.2 in CLP versus 2.2 ± 1.6 in sham;
Figure 2B). At 6 h after CLP, 25.4% of GFP-LC3 dots were
co-localized with LAMP1 signals, and this percentage in-
creased to 58.8% by 24 h after CLP (Figure 2B). To evalu-
ate autophagy flux (progression from autophagosome to
autolysosome), the amount of p62 protein was examined
[34,35]. As shown in Figure 2C, no significant difference
was observed between the sham and CLP groups at either
6 or 24 h after the operation. However p62 protein signifi-
cantly increased at 24 h compared to that at 6 h in CLP
group.
To further confirm the completion of autophagy, we
examined liver samples by transmission electron micros-
copy. The autolysosome, which has a single limiting
membrane and contains cytoplasmic/organellar mate-
rials at various stages of degradation, can be distin-
guished from the autophagosome (containing a double
limiting membrane) by electron microscopy. The in-
crease in autolysosomes in hepatocytes from sham versus
CLP mice (25.0 ± 11.5 versus 90.7 ± 17.8) per 50 images
for each mouse was statistically significant (P = 0.036) 6 h
after CLP (Figure 3A,B). These data indicated that the
autophagy process is completed in sepsis, rather than
blocked at the fusion step, consistent with the immu-
nofluorescence results. Importantly, despite an increased
number of autophagosomes in septic samples, hepatocytes
did not appear to be committed to cell death and the vast
majority of mitochondria in both sham and CLP groups
appeared normal (Figure 3B).
Protective role of autophagy in the CLP septic model
Since the autophagy machinery is activated after CLP,
we examined whether this activation is beneficial or
detrimental by inhibiting autophagy. Chloroquine, used
primarily as an antimalarial drug, inhibits fusion of the
autophagosome and lysosome by increasing autopha-
gosomal and lysosomal pH [36,37]. We first confirmed
that chloroquine (administered intraperitoneally 1 h
after CLP, to a total dose of 60 mg/kg) suppressed au-
tophagy in our CLP model. With chloroquine treatment,
the number of GFP-LC3 dots and co-localized GFP-LC3
and LAMP1 were reduced after 24 h when compared
to untreated animals in both CLP and sham-operated co-
horts (Figure 4). Thus, chloroquine treatment suppressed
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Figure 1 Cecal ligation and puncture (CLP) induces autophagy in the liver of CLP model mice. For B-D and F, data are expressed as
mean ± SD; data were analyzed for statistical significance using the Mann-Whitney test. (A) Western blotting analysis of microtubule-associated
protein light chain 3 (LC3) in the liver. Sepsis was induced by CLP. Liver samples were prepared from sham-operated and CLP mice at each
indicated time point post surgery. Results are representative of seven independent experiments. β-tubulin served as standard. (B) The ratio
between the levels of LC3-II and LC3-I at each time point. *P <0.05, as compared to sham-operated group (n = 7/group). (C) The ratio of LC3-II/
LC3-I expression in various organs at 6 and 24 h after CLP. Values in CLP mice are expressed as fold-change relative to each sham-operated
group. MLN, mesenteric lymph node. (D) LC3 mRNA expression in the liver at each time point assessed by real-time PCR. *P <0.05, as compared
to sham-operated group (n = 7/group). (E) Confocal images of liver samples obtained from GFP-LC3 transgenic mice. Green-fluorescing GFP-LC3
dots were present in the cytosol indicated by the arrow head. (F) The number of GFP-LC3 dots per cellular confocal image was quantified.
Differences in the number of GFP-LC3 dots in CLP mice at 6 h compared with sham-operated mice at 6 h and CLP mice at 24 h were statistically
significant (*P <0.05; n = 50 cells /animal; n = 4 animals).
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Figure 2 Co-localization of green fluorescent protein (GFP)-Microtubule-associated protein light chain 3 (LC3) dots with lysosome-
associated membrane protein type 1 (LAMP1) in the liver after cecal ligation and puncture (CLP). (A) Confocal images of liver samples
obtained from GFP-LC3 transgenic mice. Green-fluorescing GFP-LC3 dots were present in the cytosol. LAMP1 was stained using Cy3-conjugated
IgG secondary antibodies. Merged images demonstrate co-localization of GFP-LC3 dots and LAMP1. (B) The number of GFP-LC3 or GFP-LC3 +
LAMP1 dots per cellular confocal image was quantified at 6 and 24 h after CLP. All data are expressed as mean ± SD. Data were analyzed for
statistical significance using the Mann-Whitney test. Differences in the number of GFP-LC3 or GFP-LC3 dots in CLP mice at 6 h compared with
CLP mice at 24 h were statistically significant (*P <0.05; n = 50 cells /animal; n = 4 animals). (C) Relative expression of p62 protein in the liver at 6
and 24 h after sham or CLP operation. The amount of p62 protein was normalized to that of β-tubulin by evaluation of band intensity from
western blotting. All data were expressed as the mean ± SD. Data were analyzed for statistical significance using the Mann-Whitney test (*P <0.05;
n = 5 in each group).











Figure 3 Electron microscopic analysis of the liver. (A) The number of autophagosomes and autolysosomes are compared in CLP and sham
animals. All data are expressed as the mean ± SD. Data were analyzed for statistical significance using the Mann-Whitney test. Increase in
autolysosomes in the CLP group was statistically significant (*P <0.05; n = 3); mean increases in autophagosomes in CLP compared to sham did
not reach statistical significance. NS, not significant. (B) Images of electron microscopy of the liver; a: Liver sample obtained from sham-operated
mice. Organelles in the hepatocyte are generally intact and lysosomes do not contain discrete membrane structures, although the
inhomogeneous electron-dense material often seen in (hetero)lyosomes most certainly represent end-stage degradation of phospholipid and
other cytoplasmic materials (a material at the light microscopic level referred to as lipofuscin); b-e: CLP-operated mice. Double arrow heads
identify complex structures bounded by two membranes (autophagosomes); arrow heads identify single membrane-bound lysosomal complexes
with degraded organellar content (autolysosomes); e: the double arrow head identifies an autophagosome that clearly contains an
injured mitochondrion.
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transaminase levels. In sham-operated mice with chloro-
quine treatment, no liver damage was observed. In con-
trast, we observed mid-zonal sinusoidal congestion and
dilatation at 6 h after CLP. The congestion and dilata-
tion became greater in CLP mice given chloroquine
treatment, and was associated with subsequent liver
dysfunction (Figure 5A). Serum AST and ALT were
modestly increased at 6 and 24 h after CLP, but was sig-
nificantly elevated compared to sham and untreated CLP
animals after treatment with chloroquine (Figure 5B).
Finally, we examined the survival of CLP mice treated
with or without chloroquine. Mice with labored breath-
ing were considered moribund and were euthanized. Up
to 36 h after CLP, the number of moribund mice in the
chloroquine-treated group was significantly greater than
that in the untreated group (Figure 5C; P = 0.003). From
these data, it is evident that suppression of autophagy
accelerates liver injury, and likely contributes to the in-
creased mortality in the CLP septic model, thus sug-
gesting that induction of autophagy plays a protective
role against sepsis in this model.
Discussion
In this study, we investigated the kinetics and role of
autophagy in septic C57BL/6N mice over a 24-h period
following CLP. We augmented our analysis by taking
advantage of the unique characteristics of CLP-treated
GFP-LC3 transgenic mice, in which LC3-positive autopha-
gosomes can be directly visualized by GFP. Autophago-
some formation as assessed by LC3-I/LC3-II conversion
and GFP-LC3 dots was detected in liver, heart, and spleen,
peaking at 6 h after CLP. These findings are corroborated
by other recent reports of increased autophagy in the
heart, liver, and lungs of both CLP-treated animals and in
patients with sepsis [20-22,28]. Importantly, the time se-
quence of autophagy in these studies, with peak auto-
phagosome formation at 6 to 8 h after CLP [20,22], is also
compatible with our observations.
Autophagy is a complicated and dynamic multi-step
process. Both an increase in autophagic flux and block-
ade of the downstream steps in autophagosomal matur-
ation and lysosomal fusion may result in an increased
number of autophagosomes. Thus, monitoring autopha-
gic structures at different stages is necessary for accurate
evaluation of this process. Indeed, it has been a point of
some controversy in the literature whether the process
of autophagy, culminating in fusion of the autophago-
some with a lysosome, is completed or blocked after
CLP. We believe we have resolved this matter. Our re-
sults, using two independent measures, clearly indicate
that autophagy proceeds to completion in the liver after
CLP. First, fusion of the autophagosome and lysosome
was directly visualized using GFP-LC3 dots and LAMP1immunofluorescence. Our data indicated that the abso-
lute number of co-localized GFP-LC3 and LAMP1 sig-
nals continued to increase up to 24 h after CLP, and that
LAMP1-co-localized GFP-LC3 signals as a percentage of
total GFP-LC3 also increased to 64% by 24 h after CLP,
indicating that the ongoing process of autophagy was
proceeding to completion (unhindered formation of
autolysosomes). To our knowledge, this is the first re-
port to determine the dynamic changes in induction and
completion of autophagy using co-localized GFP-LC3
and LAMP1 signals in the CLP model of sepsis.
Second, we analyzed samples by electron microscopy,
perhaps the most reliable method for detecting auto-
phagic structures. The number of autolysosomes in he-
patocytes increased markedly after CLP compared to
samples from sham-operated mice. These observations
corroborate our earlier ultrastructural observations in
CLP-treated mice and septic human patients [28]. Stated
simply, autophagy is enhanced in hepatocytes by CLP-
induced sepsis and proceeds to completion, at least in
the earlier stages of sepsis.
A recent report by Chien and colleagues suggests that
suppression or blockade of the autophagic process may
occur at 18 h or later following CLP [22]. These obser-
vations conflict with our findings that autolysosome for-
mation increases in the liver up to 24 h after CLP. To
explore possible explanation for this discrepancy, we
examined the amount of p62 protein, a marker for au-
tophagy flux, in the liver. There were no statistically sig-
nificant differences in the amount of p62 between sham
and CLP groups at either 6 h or 24 h after the operation.
Nonetheless, we observed a statistically significant in-
crease in p62 protein at 24 h compared to 6 h in the
CLP group, in spite of the increased autolysosome for-
mation. Based on our observations, given the role of p62
in selective autophagy, we believe that rapid turnover of
autophagy is required in sepsis to remove damaged or-
ganelles from injured cells and that the rate of autoph-
agy may not be sufficient to deal with the extent of the
damage in the liver. Because of the limited number of
methods reported for monitoring autophagy flux in vivo,
further study of a combination of other sophisticated as-
says is required. It has also been reported that fusion of
autophagosomes with lysosomes is impaired in the heart
and lung by 24 h after CLP [20,24]. We cannot directly
respond to these data, but accept the possibility that the
kinetics of autophagy are different for each organ. In-
deed, Hsiao et al. demonstrated that autophagy is tran-
siently activated in the kidney at 3 h after CLP, but
declines from 6 h to 18 h as assessed by LC3-II expres-
sion [38]. It is also possible that different experimental
conditions, such as the needle used for CLP, the amount
and type of water and food intake after surgery, the in-
testinal microbiomes of the subject animal, and the
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Figure 4 Blockade of the autophagic process by chloroquine. Green fluorescent protein- microtubule-associated protein light chain 3
(GFP-LC3) transgenic mice were administered saline or chloroquine (CQ) (60 mg/kg intraperitoneally) at 1 h after CLP or sham surgery. Samples
were obtained from 6 or 24 h after surgery. (A) Confocal images of liver samples obtained from GFP-LC3 transgenic mice with or without CQ
treatment. Blockade of autophagic process is indicated by the arrow head. (B) The number of GFP-LC3 or GFP-LC3 + lysosome-associated
membrane protein type 1 (LAMP1) dots per cellular confocal image obtained from GFP-LC3 transgenic mice with or without CQ treatment was
quantified at 6 and 24 h after cecal ligation and puncture (CLP). All data are expressed as the mean ± SD. Data were analyzed for statistical
significance using the Student-Newman-Keuls test. Differences in the number of GFP-LC3 or GFP-LC3 + LAMP1 dots in CLP mice at 24 h
compared with CLP mice at 24 h were statistically significant (*P <0.05; n = 50 cells /animal; n = 4 animals).









Figure 5 Inhibition of autophagy enhances cecal ligation and puncture (CLP)-induced liver injury. (A) Histological findings of mouse liver
by hematoxylin and eosin staining (original magnification 100×) with a larger view (insets, 400×). Liver tissue was obtained from either sham-
operated or CLP mice with or without chloroquine (CQ) treatment 6 h after surgery. (B) Hepatocellular damage as defined by serum aspartate
aminotransferase (AST) and arginin aminotransferase (ALT) levels. Samples were obtained from either sham-operated or CLP mice with or without
CQ treatment 6 and 24 h after surgery (n = 7/group). Data are shown as mean ± SD. *P <0.05 versus saline treatment (one-way analysis of
variance); individual group means were compared using the Student-Newman-Keuls test. (C) Survival after CQ or sterile saline administration
(n = 18/group) in sham-operated or CLP mice; 3/18 mice in the CLP + saline group and 12/18 mice in the CLP + CQ group were sacrificed
because they were moribund. Comparisons of overall survival were performed using the log-rank test (P = 0.003; CLP + saline versus CLP + CQ).
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http://ccforum.com/content/17/4/R160housing conditions of the animals before and after sur-
gery (for example, room temperature, humidity, and
noise) may influence the results. Another possible ex-
planation for this discrepancy may be the use of GFP-
LC3 transgenic mice to monitor this process. The recent
study by Lo et al. demonstrates that overexpression of
LC3 protein facilitates the process of autophagy in the
lung in a CLP model [24]. These data suggest that the
amount of LC3 protein might be the rate-limiting factor.
Further study to analyze baseline LC3 quantities in sham
and GFP-LC3 mice may help resolve this matter.
It is generally accepted that autophagy promotes sur-
vival by supporting metabolism and mitigating damage
by eliminating debris at the cellular level [6,19]. Block-
ade of autophagy by chloroquine resulted in liver dys-
function accompanied by an increase in serum AST and
ALT at 6 and 24 h after CLP. Taken together, these find-
ings support our survival data and suggest that the liver
plays a key role during sepsis. Hepatocytes contribute to
host defense by upregulating inflammatory responses by
production of IL-6, C-reactive protein, fibrinogen, and
thrombin. On the other hand, hemodynamic changes
and excessive levels of inflammatory cytokines in early
sepsis likely cause liver damage. Interestingly, induction
of autophagy protects against the hepatotoxicity of acet-
aminophen [39] and ethanol [31]. In the latter setting,
removal of damaged mitochondria by autophagy may be
responsible for preventing hepatic cell apoptosis [31].
Previous reports also indicated that hepatocyte resis-
tance to injury by oxidative stress is mediated by auto-
phagy [27], and that impaired autophagy may promote
oxidative-induced liver injury associated with over-
activation of the JNK signaling pathway that induces cell
death [40]. In the liver, autophagy is important for
maintaining the balance of energy and nutrients for cell
functions, removal of misfolded proteins, resistance to
oxidative stress [40], and turnover of mitochondria un-
der both normal and physiological conditions. Thus, dis-
turbance of autophagy in the liver could have a major
impact on liver physiology and disease [41-43]. Our data
suggest that suppression of autophagy by chloroquine
after CLP is in fact detrimental. Histological examination
of the liver revealed that mid-zonal sinusoidal conges-
tion and dilatation became greater in CLP operated mice
given chloroquine treatment compared to untreated
mice. However, no evidence of hepatocellular necrosis
was observed in the chloroquine treatment group at 6 or
24 h after the operation. We believe that the primary ef-
fect of autophagy inhibition in hepatocytes is to prevent
damaged organelles such as mitochondria from being
targeted for autophagic clearance. Although chloroquine
has pleiotropic pharmacological activities and is not a
specific inhibitor of autophagy, it nonetheless selectively
interferes with autophagosome/lysosome fusion(presumably by increasing lysosomal pH). Even so, it re-
mains unclear from our observations how autophagy in
hepatocytes plays a protective role against CLP-induced
liver dysfunction and overall survival, since suppression
of autophagy by chloroquine is not liver-specific. Perhaps
the role of autophagy in CLP-induced sepsis in each
organ will be clarified by using organ-specific autophagy-
conditional knockout mice.
Several reports have demonstrated that induction of
autophagy by other pharmacological agents, such as
rapamycin, improves cardiac function and inflammatory
responses in CLP mice [20,24,44-46]. However, since
there are no autophagy-specific inhibitors or inducers
available at this time, we must be careful in interpreting
these data. Nevertheless, activation of autophagy could
be a potential therapeutic target in sepsis, since our data
suggest that induction of autophagy in the early phase of
sepsis may support immunomodulation. Recent data
measured by ICU resource use and infection rates in-
dicate that early parenteral nutrition in critically ill
patients is harmful [47]. We might infer, then, that in-
duction of autophagy by means of nutrient deprivation
in the acute phase of sepsis may be beneficial, particu-
larly for those patients with signs of severe sepsis.Conclusions
In conclusion, we have shown that autophagy is induced
in several organs in the first 24 h after CLP in an animal
model of sepsis, and that the entire process of auto-
phagy, from early envelopment of damaged cytosolic ele-
ments to fusion of autophagosomes with lysosomes, is
activated in liver. We also conclude that autophagy plays
a protective role in organ dysfunction during sepsis. De-
velopment of specific modulators of autophagy and the
means to monitor autophagy in real time will be critical
to the successful introduction of pro-autophagic therap-
ies to the field of critical care medicine.Key messages
 All intact autophagy-related processes are
activated rather than suppressed in liver in a mouse
CLP-induced sepis model.
 Autophagy plays a protective role against sepsis.
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